C

Clinical Research Philadelphia | Philadelphia, PA

Research site

(Unclaimed)

Location

9501 Roosevelt Boulevard, Suit 208, Philadelphia, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Amlitelimab

Rimegepant

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 5 total trials

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 1)

This is a parallel group, Phase 3, multinational, multicenter, randomized, double blind, placebo-controlled, 3-arm monotherapy study for treatment of...

Enrolling

Dermatitis Atopic

Drug: Amlitelimab

Drug: Placebo

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor (AQUA)

This is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study for treatment of participant...

Enrolling

Dermatitis Atopic

Drug: Amlitelimab

Drug: Topical corticosteroids

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic m...

Active, not recruiting

Photophobia

Migraine

Drug: Rimegepant

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms